This article reviews current noninvasive tools available for the early screening and diagnosis of coronary artery disease.
Answers are grounded in this paper and cite their sources.
Offers clinicians a summary of noninvasive CAD screening tools; leaves open comparative effectiveness research to guide implementation.
Heart disease is the leading cause of death in the Western world. More than 500,000 menand women die from coronary artery disease (CAD) each year in the USA. Despiterecent decreases in mortality, heart disease remains the leading cause of death in theUSA for men and women. The search for an accurate, noninvasive and lower-risktechnique for diagnosing CAD continues to challenge researchers globally. This iscomplicated by the fact that in up to 50% of the patients the first manifestation of CADis either myocardial infarction or death. During the past 2 decades, major strides havebeen made in the diagnosis and treatment of heart disease. Major emphasis has beenplaced on early screening, diagnosis and risk stratification. The ideal screening test shouldbe one that is noninvasive, inexpensive, accurate and easily accessible and has highersensitivity and specificity. In this article, the authors review the current noninvasive toolsavailable to cardiologists and primary care physicians for early screening and diagnosisof CAD.
No takes yet. Share an insight, caveat, or question.
Gul et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: